5 Best Dividend Stocks According to John Overdeck And David Siegel’s Two Sigma Advisors

4. Amgen Inc. (NASDAQ:AMGN)

Number of Hedge Fund Holders: 52
Dividend Yield as of January 18: 3.32%

Amgen Inc. (NASDAQ:AMGN) announced a 10.2% increase in its quarterly dividend on December 3, 2021, at $1.94 per share. The stock’s current dividend yield stands at 3.32%. Amgen Inc. (NASDAQ:AMGN) has been paying dividends for the past 11 years and has increased its dividend at a CAGR of 11.97% in the past five years.

In January, RBC Capital set a $255 price target on Amgen Inc. (NASDAQ:AMGN), with a Neutral rating on the shares. In Q3 2021, Two Sigma Advisors increased its position in the company by 45% and now holds a stake worth roughly $394 million. Amgen Inc. (NASDAQ:AMGN) accounted for 1.04% of John Overdeck and David Siegel’s 13F portfolio.

As per Insider Monkey’s data for Q3, 52 hedge funds held stakes in Amgen Inc. (NASDAQ:AMGN), down from 53 in the previous quarter. The total value of these stakes is over $1.44 billion. Among these hedge funds, D E Shaw was one of the company’s largest shareholders in Q3, with shares worth over $267 million.

ClearBridge Investments mentioned Amgen Inc. (NASDAQ:AMGN) in its recently-published Q3 2021 investor letter. Here is what the firm has to say:

“In health care, Amgen, a biotechnology company, has endured several pipeline setbacks recently, including a slow transition of its Lumakras treatment into first-line lung cancer, a slower than expected development of its treatment for myeloma as well as the company’s asthma treatment Tezepelumab missing its primary endpoint in a Phase III study. We remain positive on the stock, with Amgen’s investments in biosimilars and its pipeline part of our long-term thesis.”